Hematology tests in Dubai & UAE

Compare available Hematology tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

114

Listed price range

550.00–7,500.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Hematology test prices

Showing 76–90 of 114 matching tests.

Hematology diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2561 MIXING STUDIES Test This test evaluates the cause of a prolonged aPTT by assessing whether the prolongation corrects upon mixing the patient's plasma with normal plasma.	Whole Blood	Next Day (if sample collected by 11 AM on Wednesday or Saturday)	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Clotting factor deficiency", "Presence of circulating inhibitors"] Parameters [{"name": "aPTT (Patient)", "reference_range": null}, {"name": "aPTT (Mixed)", "reference_range": null}, {"name": "Inhibitor Index", "reference_range": null}] Preparation ["Fasting overnight is preferred.", "Complete the mandatory Coagulation Requisition Form 15.", "Follow physician's advice regarding temporary discontinuation of anticoagulants (heparin, warfarin, DOACs)."] Indications ["Evaluation of prolonged aPTT", "Diagnosis of bleeding disorders", "Differentiation between factor deficiency and inhibitor"] Measurement technique Confirm with laboratory Codes LOINC: 14974-9 ICD-10: D68.9 Clinical summary This test evaluates the cause of a prolonged aPTT by assessing whether the prolongation corrects upon mixing the patient's plasma with normal plasma.
TEST-1333 MLL (KMT2A) Gene Rearrangement by FISH Test This diagnostic test evaluates for rearrangements within the MLL (KMT2A) gene, a key prognostic marker in acute leukemias.	Bone marrow aspirate or peripheral blood	3–4 working days	700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MLL (KMT2A) gene rearrangement", "Chromosome 11q23 translocation"] Parameters [] Preparation [] Indications ["Risk stratification in AML", "Risk stratification in ALL", "Guiding targeted therapy", "Determining transplant timing"] Measurement technique Confirm with laboratory Codes LOINC: 33679-2 ICD-10: C92.00 Clinical summary This diagnostic test evaluates for rearrangements within the MLL (KMT2A) gene, a key prognostic marker in acute leukemias.
TEST-2579 Monoclonal Gammopathy of Undetermined Significance (MGUS) Panel Test This diagnostic test evaluates the presence, quantity, and type of monoclonal immunoglobulins (M-proteins) in the serum.	Serum (peripheral blood)	Next-day report (sample received by 9 AM)	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Monoclonal Immunoglobulins (M-proteins)", "Serum Free Light Chains (via reflex testing)"] Parameters [{"name": "Serum Protein Electrophoresis (SPEP)", "reference_range": "Normal range varies by lab; typically shows distinct albumin and globulin bands without a monoclonal spike."}, {"name": "Immunofixation Electrophoresis (IFE)", "reference_range": "Negative for monoclonal protein."}, {"name": "Serum Free Light Chains (Kappa/Lambda Ratio)", "reference_range": "Normal range typically 0.26-1.65 (lab specific)."}, {"name": "Nephelometry (IgG, IgA, IgM)", "reference_range": "Lab specific reference ranges for each immunoglobulin class."}] Preparation ["No special preparation needed", "Do not discontinue prescribed medication"] Indications ["Screening for plasma cell disorders", "Evaluation of unexplained proteinuria", "Monitoring known MGUS", "Investigation of suspected multiple myeloma or AL amyloidosis"] Measurement technique Confirm with laboratory Codes LOINC: 24558-5 ICD-10: D47.2 Clinical summary This diagnostic test evaluates the presence, quantity, and type of monoclonal immunoglobulins (M-proteins) in the serum.
TEST-2595 Multiple Myeloma Comprehensive Profile (MMCP) Test This diagnostic test evaluates for the presence and characteristics of monoclonal proteins, plasma cell clonality, and related hematological parameters to diagnose and monitor mult...	Peripheral Blood & Bone Marrow Aspirate	3 Working Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Monoclonal protein (M-protein)", "Kappa/lambda free light chains", "Complete blood count", "Plasma cell clonality", "Immunoglobulins", "CD38/CD138/CD45/CD19/CD56 expression"] Parameters [{"name": "Serum Protein Electrophoresis (SPEP)", "reference_range": null}, {"name": "Serum Immunofixation", "reference_range": null}, {"name": "Serum Free Light Chains (Kappa/Lambda)", "reference_range": null}, {"name": "Quantitative Immunoglobulins (IgG, IgA, IgM)", "reference_range": null}, {"name": "Complete Blood Count (CBC)", "reference_range": null}, {"name": "Bone Marrow Flow Cytometry (CD38/CD138/CD45/CD19/CD56)", "reference_range": null}] Preparation ["No specific fasting required.", "Inform the laboratory if on anti-CD38 monoclonal antibody therapy."] Indications ["Suspected multiple myeloma", "Evaluation of monoclonal gammopathy", "Staging of plasma cell disorders", "Monitoring treatment response", "Assessing minimal residual disease"] Measurement technique Confirm with laboratory Codes LOINC: 80735-0 ICD-10: C90.0, D47.2 Clinical summary This diagnostic test evaluates for the presence and characteristics of monoclonal proteins, plasma cell clonality, and related hematological parameters to diagnose and monitor multiple myeloma.
TEST-2581 Multiple Myeloma Monitoring Panel Test This test evaluates monoclonal gammopathies by quantifying M-protein and free light chains to track disease activity in multiple myeloma.	Serum & Plasma (Peripheral Whole Blood)	Next working day (sample received by 9 AM)	1,300.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["M-protein quantification", "Free light chain quantification", "Monoclonal gammopathy activity"] Parameters [{"name": "M-protein", "reference_range": null}, {"name": "Free Light Chains", "reference_range": null}] Preparation ["Inform the phlebotomist if you have an active infection, recent vaccination (within 2 weeks), or are pregnant."] Indications ["Monitoring disease progression in multiple myeloma", "Assessing treatment response", "Risk stratification"] Measurement technique Confirm with laboratory Codes LOINC: 24360-0 ICD-10: C90.00, C90.01, C90.02 Clinical summary This test evaluates monoclonal gammopathies by quantifying M-protein and free light chains to track disease activity in multiple myeloma.
TEST-2600 Multiple Myeloma Screening Panel Test This diagnostic test evaluates serum for the presence and type of monoclonal proteins and free light chains, aiding in the screening for monoclonal gammopathies.	Serum (5 mL SST)	Next Working Day (sample by 9 AM)	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Monoclonal proteins (M-proteins)", "Free light chains (kappa and lambda)", "Serum protein electrophoresis patterns"] Parameters [{"name": "Serum Protein Electrophoresis", "reference_range": "Normal patterns show albumin, alpha-1, alpha-2, beta, and gamma globulin bands without a discrete monoclonal spike."}, {"name": "Immunofixation Electrophoresis", "reference_range": "Negative for monoclonal protein (M-protein)."}, {"name": "Free Light Chain Assay (Kappa/Lambda)", "reference_range": "Normal kappa/lambda ratio (typically 0.26-1.65)."}] Preparation ["No fasting required", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Screening for multiple myeloma", "Screening for MGUS", "Evaluation of unexplained anemia or kidney problems", "Monitoring known monoclonal gammopathies"] Measurement technique Confirm with laboratory Codes LOINC: 34058-7 ICD-10: C90.00, Z12.89 Clinical summary This diagnostic test evaluates serum for the presence and type of monoclonal proteins and free light chains, aiding in the screening for monoclonal gammopathies.
TEST-1329 Multiplex Leukemia Cytogenetics & PCR Panel (28 Translocations, 80 Breakpoints: CML, AML, ALL) Test This diagnostic panel evaluates for 28 specific chromosomal translocations and 80 breakpoints commonly associated with CML, AML, and ALL.	Peripheral Blood (PCR) & Bone Marrow Aspirate (Cytogenetics)	5–7 working days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Chromosomal translocations", "Breakpoint analysis", "Minimal residual disease (MRD)"] Parameters [] Preparation ["No specific fasting required for peripheral blood.", "Follow physician's instructions regarding medication adjustments."] Indications ["Diagnosis of suspected leukemia (CML, AML, ALL)", "Risk stratification in leukemia", "Monitoring minimal residual disease (MRD)", "Guiding treatment decisions"] Measurement technique Confirm with laboratory Codes LOINC: 34565-3 ICD-10: C92.0, C91.0, C92.1 Clinical summary This diagnostic panel evaluates for 28 specific chromosomal translocations and 80 breakpoints commonly associated with CML, AML, and ALL.
TEST-2613 Myeloproliferative Neoplasm with Eosinophilia (MPN-Eo) Test This test evaluates for specific gene rearrangements (PDGFRA, PDGFRB, FGFR1, JAK2) associated with Myeloproliferative Neoplasm with Eosinophilia (MPN-Eo) using FISH and morphology.	Peripheral Blood & Bone Marrow Aspirate / Biopsy	7 working days	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Gene rearrangements in PDGFRA", "Gene rearrangements in PDGFRB", "Gene rearrangements in FGFR1", "Gene rearrangements in JAK2", "Bone marrow morphology", "Peripheral blood cell counts"] Parameters [] Preparation ["A fully completed Chromosome & FISH Analysis Requisition Form (Form 17) is mandatory before sample collection."] Indications ["Suspicion of Myeloproliferative Neoplasm with Eosinophilia (MPN-Eo)", "Evaluation for targeted tyrosine kinase inhibitor therapy"] Measurement technique Confirm with laboratory Codes LOINC: 48768-6 ICD-10: D47.2, D72.1 Clinical summary This test evaluates for specific gene rearrangements (PDGFRA, PDGFRB, FGFR1, JAK2) associated with Myeloproliferative Neoplasm with Eosinophilia (MPN-Eo) using FISH and morphology.
TEST-1318 MYEOV/IgH Translocation (Multiple Myeloma) FISH Test This test detects the t(11;14)(q13;q32) translocation using Fluorescence In-Situ Hybridization (FISH). It identifies a specific genetic rearrangement associated with multiple myelo...	Bone Marrow Aspirate / Peripheral Blood	3–4 Working Days	700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["t(11;14)(q13;q32) translocation", "MYEOV oncogene rearrangement", "Immunoglobulin heavy chain (IgH) locus rearrangement"] Parameters [] Preparation [] Indications ["Diagnosis and risk stratification of multiple myeloma", "Guidance for targeted therapy selection (e.g., venetoclax)", "Monitoring disease progression"] Measurement technique Confirm with laboratory Codes LOINC: 60512-6 ICD-10: C90.00, C90.01, C90.02 Clinical summary This test detects the t(11;14)(q13;q32) translocation using Fluorescence In-Situ Hybridization (FISH). It identifies a specific genetic rearrangement associated with multiple myeloma.
TEST-2702 NPM1 Gene Mutation Quantitative MRD Monitor Test This test quantifies the level of NPM1 gene mutation in a blood sample to detect minimal residual disease (MRD) in AML patients.	Blood (EDTA tube)	Sample Mon/Thu 11am ⇒ Report Wed/Sat	850.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NPM1 gene mutation levels", "Minimal Residual Disease (MRD)"] Parameters [] Preparation ["No fasting required", "Sample must be collected in a lavender-top EDTA tube", "Sample must be transported refrigerated, never frozen"] Indications ["Monitoring treatment response in NPM1-mutated AML", "Predicting relapse risk in NPM1-mutated AML"] Measurement technique Confirm with laboratory Codes LOINC: 78579-2 ICD-10: C92.0 Clinical summary This test quantifies the level of NPM1 gene mutation in a blood sample to detect minimal residual disease (MRD) in AML patients.
TEST-2709 Nutritional Anemia Panel Test This diagnostic test evaluates serum iron, TIBC, ferritin, vitamin B12, folate, and CBC to identify nutritional causes of anemia.	Peripheral Whole Blood, Serum	24 hours	700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Serum Iron", "Total Iron-Binding Capacity (TIBC)", "Ferritin", "Vitamin B12", "Folate", "Complete Blood Count (CBC) with Reticulocyte Indices"] Parameters [{"name": "Serum Iron", "reference_range": null}, {"name": "Total Iron-Binding Capacity (TIBC)", "reference_range": null}, {"name": "Ferritin", "reference_range": null}, {"name": "Vitamin B12", "reference_range": null}, {"name": "Folate", "reference_range": null}, {"name": "Complete Blood Count (CBC)", "reference_range": null}, {"name": "Reticulocyte Indices", "reference_range": null}] Preparation ["Overnight fasting for 8–12 hours is recommended.", "Avoid iron supplements for 24 hours prior.", "Sampling before noon is preferable."] Indications ["Suspected iron deficiency anemia", "Suspected vitamin B12 deficiency (pernicious anemia)", "Suspected folate deficiency anemia", "Evaluation of fatigue and weakness", "Monitoring response to nutritional therapy"] Measurement technique Confirm with laboratory Codes LOINC: 24320-4 ICD-10: D50.9, E53.8, D52.0 Clinical summary This diagnostic test evaluates serum iron, TIBC, ferritin, vitamin B12, folate, and CBC to identify nutritional causes of anemia.
TEST-2786 ONCOMINE Acute Myeloid Leukaemia (AML) Panel Test This test identifies genetic mutations in over 25 genes relevant to Acute Myeloid Leukaemia (AML) using Next-Generation Sequencing.	Blood (Lavender-top EDTA tube) or Bone Marrow Aspirate	15 working days (monthly batch processing)	4,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mutations in NPM1 gene", "Mutations in FLT3 gene", "Mutations in IDH1 gene", "Mutations in IDH2 gene", "Mutations in CEBPA gene", "Other AML-associated gene mutations"] Parameters [] Preparation ["No specific fasting required", "Inform lab if patient received bone marrow transplant within 28 days", "Ensure fully completed NGS Requisition Form (Form 40) is provided"] Indications ["Diagnosis of Acute Myeloid Leukaemia", "Risk stratification in AML", "Guidance for targeted therapy selection", "Monitoring for minimal residual disease (if applicable)"] Measurement technique Confirm with laboratory Codes LOINC: 88229-0 ICD-10: C92.00 Clinical summary This test identifies genetic mutations in over 25 genes relevant to Acute Myeloid Leukaemia (AML) using Next-Generation Sequencing.
TEST-2795 Oncomine Juvenile Myelomonocytic Leukemia (JMML) Panel Test This diagnostic test evaluates the genetic mutations in 42 key genes associated with juvenile myelomonocytic leukemia (JMML) using next-generation sequencing.	Bone marrow aspirate or peripheral whole blood (EDTA)	Batch processing: sample by 1st/16th, report 15th/30th same month	4,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants (SNVs)", "Insertions/deletions (Indels)", "Copy number alterations (CNAs)", "Mutations in 42 specific genes (e.g., PTPN11, NRAS, KRAS, NF1, CBL)"] Parameters [] Preparation ["No specific patient preparation required."] Indications ["Suspicion of juvenile myelomonocytic leukemia", "Risk stratification in JMML", "Guiding targeted therapy decisions"] Measurement technique Confirm with laboratory Codes LOINC: 96972-0 ICD-10: C93.3 Clinical summary This diagnostic test evaluates the genetic mutations in 42 key genes associated with juvenile myelomonocytic leukemia (JMML) using next-generation sequencing.
TEST-2848 Paroxysmal Nocturnal Hemoglobinuria (PNH) Confirmatory Test This test definitively identifies PNH clones by detecting the absence of GPI-anchored proteins on blood cells, confirming a life-threatening hematopoietic stem cell disorder.	Whole Blood (EDTA & Sodium Heparin tubes)	Same day (report by 9 PM)	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Glycosylphosphatidylinositol (GPI)-anchored protein deficiency", "PNH clone size on erythrocytes and leukocytes"] Parameters [{"name": "PNH Clone Size (RBCs)", "reference_range": " Preparation ["No fasting required", "Inform phlebotomist of all medications and recent transfusions", "Avoid non-essential supplements that may affect coagulation (e.g., high-dose vitamin E, fish oil) on the day of collection"] Indications ["Definitive diagnosis of PNH", "Monitoring of complement inhibitor therapy", "Technical validation of flow cytometry findings", "Screening for unexplained anemia or thrombosis"] Measurement technique Confirm with laboratory Codes LOINC: 93975-0 ICD-10: D59.5 Clinical summary This test definitively identifies PNH clones by detecting the absence of GPI-anchored proteins on blood cells, confirming a life-threatening hematopoietic stem cell disorder.
TEST-1211 PDGFRA (4q12) Gene Rearrangement FISH Test This test detects rearrangements in the PDGFRA gene located on chromosome 4q12 using FISH technology.	Bone Marrow Aspirate or Peripheral Whole Blood (Sodium Heparin Green Top)	4 Working Days	850.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PDGFRA gene rearrangements", "Cryptic fusions and deletions at 4q12 locus"] Parameters [] Preparation ["No special preparation like fasting is required", "Inform your doctor if on blood thinners before bone marrow procedure"] Indications ["Diagnosis of chronic eosinophilic leukemia (CEL)", "Identification of patients for targeted therapy (e.g., Imatinib)", "Evaluation of myeloproliferative neoplasms with eosinophilia"] Measurement technique Confirm with laboratory Codes LOINC: 49492-3 ICD-10: C92.3, D47.8 Clinical summary This test detects rearrangements in the PDGFRA gene located on chromosome 4q12 using FISH technology.

Category overview

Hematology: overview

When it comes to your circulatory health, finding precise and timely answers is essential for your peace of mind and ongoing vitality. The Hematology department at DNA Labs UAE uses highly advanced flow cytometry and automated cell counters to thoroughly analyze your blood profile. From routine counts to specialized coagulation and hematology testing in the UAE, these diagnostics provide your doctor with crucial data to manage and monitor blood-related conditions effectively. Trust in one of the most reliable diagnostic labs in Dubai and the UAE to deliver fast, highly accurate results under uncompromising confidentiality standards. Ensure your circulatory wellness today. View our hematology tests, arrange a convenient home collection, or contact our medical experts to schedule your visit.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Hematology tests in Dubai & UAE

Hematology test prices

Hematology: overview

Use the test details as a conversation starter

Related Hematology categories